Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

AstraZeneca team presents new P2X7 antagonists

Oct. 14, 2004

New NO-releasing COX inhibitors in early development at Altana

Oct. 14, 2004

Novel gastric antisecretory agents discovered at Altana

Oct. 14, 2004

Celltech researchers claim anti-IL-1beta antibodies and their use

Oct. 14, 2004

New p38 MAP kinase inhibitors and their use claimed by Pfizer

Oct. 13, 2004

New Nurr1 activators with potential utility in PD therapy

Oct. 13, 2004

Novel ALK4/ALK5 inhibitors discovered at Biogen Idec

Oct. 13, 2004

New androgen receptor antagonists in early development at Pfizer

Oct. 13, 2004

Two series of PTP inhibitors presented by TransTech researchers

Oct. 13, 2004

Novel chemokine CCR3 modulators and their use described by Boehringer Ingelheim

Oct. 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...